- Does your trial/pilot structure respond to changing conditions?
- What does innovation mean to you? Process innovation? Delivery of care? Patient engagement?
AMOS ADLER M.Sc. FOUNDER & PRESIDENT Amos brings speech, mobile and social technologies together to create mobile (mHealth) and telehealth patient adherence programs. Since 2008, Amos has led the design and deployment of dozens of digital patient adherence and behavior change programs globally while advocating for evidence-based approaches to technology-based behavior change. With a background in user oriented design methodologies, user-requirements elicitation, finance and enterprise scale technology deployment, Amos focuses on solutions solving real-world business requirements with patient centered designs while understanding the challenges of change management in clinical settings. Prior to founding MEMOTEXT, Amos held multiple technology and finance related positions within the Bell Canada Holdings family of companies as well as a background in social and private real estate development. Amos holds a M.Sc. in Analysis, Design and Management of Information Systems from The London School of Economics in London England, graduating with distinction was highlighted by his work within the launch of the world’s first independent exchange for international wholesale telecom capacity. Amos speaks regularly at events such as: mHealth, Stanford Mobile Health, Health Datapalooza, Genentech FutureMed2.0 and has guest lectured at the Univ. of Toronto